期刊文献+

子痫前期孕妇尿液VEGF、sFlt-1水平的变化及意义 被引量:3

Changes in Urine VEGF and sFlt-1Levels and Their Significance in Pregnant Women with Preeclampsia
下载PDF
导出
摘要 目的研究子痫前期孕妇尿液血管内皮生长因子(VEGF)及可溶性血管内皮生长因子受体1(sFlt-1)水平变化及其与病情程度的关系。方法采用ELISA方法检测轻度子痫前期孕妇(A组,32例)、重度子痫前期孕妇(B组,28例)、正常孕妇(C组,30例)尿液VEGF、sFlt-1水平。结果 3组孕妇尿液VEGF、sFlt-1水平比较差异均有统计学意义(均P<0.01)。C组尿液VEGF水平显著高于A、B组(P<0.01),而sFlt-1水平显著低于A、B组(P<0.01);A组尿液VEGF水平显著高于B组(P<0.01),而sFlt-1水平显著低于B组(P<0.01)。结论孕妇尿液中VEGF水平的降低、sFlt-1水平的升高与子痫前期病情程度有关,通过检测孕妇尿液VEGF、sFlt-1水平可能可以预测子痫前期的发生。 Objective To investigate the levels of vascular endothelial growth factor(VEGF) and soluble vascular endothelial growth factor receptors 1(sFlt-1)in urine and their relationship to the degree of illness in pregnant women with preeclampsia.Methods Urinary levels of VEGF and sFlt-1were measured by ELISA in 32pregnant women with mild preeclampsia(group A),28 pregnant women with severe preeclampsia(group B)and 30normal pregnant women(group C).Results Compared with group A,VEGF levels significantly increased in group C but decreased in group B(P&lt;0.01).However,sFlt-1levels significantly decreased in group C but increased in group B compared with group A(P&lt;0.01).Conclusion The decrease in VEGF and increased in sFlt-1in urine is associated with the degree of preeclampsia.Maternal urine VEGF and sFlt-1can be used as predictive markers of preeclampsia.
出处 《南昌大学学报(医学版)》 CAS 2013年第8期42-43,103,共3页 Journal of Nanchang University:Medical Sciences
关键词 子痫前期 血管内皮生长因子 可溶性血管内皮生长因子受体1 孕妇 preeclampsia vascular endothelial growth factor soluble vascular endothelial growth factor receptors 1 pregnant women
  • 相关文献

参考文献7

  • 1Roberts J M,Cooper D W. Pathogrenesis and genetics of pre- eclampsia [J]. Lancet, 2001,357(1) : 53-56.
  • 2Wu F T, Stefanini M O,Mac Gabhann F,et al. A systems biol- ogy perspective on sVEGFRI:its biological function, function, pathogenic role and therapeutic use[J]. J Cell Mol Med, 2010, 14(3) :528-552.
  • 3Shibuya M. Involvement of Flt-1 (VEGF receptor-l) in cancer and preeclampsia[J]. Proc Jpn Aead Ser B Phys Biol Sei,2011, 87(4) :167-168.
  • 4Man Maynard S E,Min J Y, Merehan J,et al. Excess placental soluble fins-like turosine l(sFlt-1) may contribute to endotheli- al dysfunction, hypertension, and proteinuria in preeclamps-ia[J]. J Clin Invest,2003,111(5) :649-658.
  • 5陶娅玲,漆洪波.子痫前期孕妇血清及尿液中VEGF、PLGF、sFlt-1水平变化及意义[J].实用妇产科杂志,2008,24(8):496-498. 被引量:15
  • 6Hertig A, Berkane N, Lefevre G, et al. Maternal serum sFlt-1 concentrarion is an early and reliable predictive marker of pre- eclampsia[J]. Clin Chem, 2004,50(7) : 1702-1703.
  • 7Levine R J, Maynard S E, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia[J]. N Engl J Med, 2004, 350(11) :672-683.

二级参考文献9

  • 1David L. Placental protein may have a role in preeclampsia[J].Lancet, 2003,361 (2) :940 - 941.
  • 2Roberts JM, Cooper DW, Pathogenesis and genetics of pre- eclampsia [J]. Lancet,2001,357(1) :53 -56.
  • 3Bdolah Y, Sukhatme VP, Karumanchi SA. Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights [ J ].J Semin Nephrol, 2004,7(6) :548 - 556.
  • 4Thomas S, Vanuystel J, Gruden G, et al. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease [J] .J Am Soc Nephrol, 2000,11(5):1236- 1243.
  • 5Simon M, Grone HJ, Johren O, et al. Vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidneys[J]. Am J Physiol, 1995,268(11): 240-250.
  • 6Eremina V, Sood M, Haigh J, et al. Glomerular- specific alterations of VEGF expression lead to distinct congenital and acquired renal diseases [J].J Clin Invest, 2003,111(2):707-716.
  • 7Hertig A, Berkane N, Lefevre G, et al. Maternal serum sFlt-1 concentration is an early and reliable predictive marker of preeclampsia[ J] .Clinical Chemistry, 2004,50(7):1702- 1703.
  • 8Fayyad AM, Harfington KF. Prediction and prevention of preeclampsia and IUGR[J]. Early Hum Dev, 2005,81(6):865-876.
  • 9Levine R J, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of reeclampsia[J]. N Engl J Med, 2004,350(11):672-683.

共引文献14

同被引文献25

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部